secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cencora, Inc. (COR)
CIK:        0001140859
Form:       8-K
Filed at:   2025-01-02T23:59:59+00:00
Accession:  0001104659-25-000366
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 2.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cencora completes $4.4B acquisition of Retina Consultants of America; raises FY2025 adjusted EPS guidance
--------------------------------------------------------------------------------

- Cencora acquires ~85% interest in Retina Consultants of America for $4.4B cash outlay, with post-closing adjustment.
- RCA becomes Cencora subsidiary; certain RCA physicians and management retain minority equity interest.
- FY2025 adjusted diluted EPS guidance raised to $15.15-$15.45 from prior $14.80-$15.10, reflecting RCA contribution and momentum.
- Acquisition expands Cencora's specialty leadership, MSO solutions, and value for physicians and patients.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1140859/000110465925000366/0001104659-25-000366-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1140859/000110465925000366/tm2432308d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-000366

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer